20, 30, 40% 13-93B3 in PMMA
cement |
5, 33, 100 μm BBG successfully added in
PMMA69
|
20, 30,
40% 13-93B3 in PMMA
cement |
Modulus and compressive strength of 3 GPa and
130 MPa, respectively
were achieved10
|
10, 20, 30% SrBG in PMMA cement |
Modulus and compressive
strength of 3.15 GPa and 90 MPa, respectively
were achieved. % viability of MC3T3-E1 cells after treatment with
cements showed biocompatibility of the composite70
|
13-93B3 in chitosan-based
scaffold |
Injectable scaffolds were successfully prepared. |
Compressive strength of up to 30 MPa was obtained. |
Up to 50% of the scaffolds degraded in 30 days26
|
13-93B3 scaffold with PCL coating |
Compressive strength of
240 MPa was achieved64
|
13-93B particles coated with
WS2 incorporated PCL/PLGA |
0.1–2 wt % WS2 particles improved
strength and in vitro bioactivity. Up to 1 wt
% WS2 nanoparticles improved % MC3T3-E1 cell viability65
|
Particles coated with
PCL/PLGA/hexagonal boron nitride |
Compressive strength
of 3.23 MPa was achieved after addition
of 0.2 wt % boron nitride. Samples were found biocompatible with MC3T3-E1
cells106
|
13-93B3 in gelatin with citric
acid scaffold |
Highly bioactive injectable scaffolds
were successfully achieved63
|
13-93B3 with platelet rich
plasma
scaffold |
Incorporation of platelet rich plasma improved
bone healing,
in vivo71
|